Glassman Wealth Services Rocket Pharmaceuticals, Inc. Transaction History

Glassman Wealth Services

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$21.52 - $36.02 $1,226 - $2,053	-57 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$27.42 - $48.97 $1,508 - $2,693	55 Added 2750.0%	57 $2,000
Q2 2021 Aug 04, 2021	SELL	$39.41 - $47.25 $2,128 - $2,551	-54 Reduced 96.43%	2 $0
Q1 2021 May 05, 2021	BUY	$43.34 - $65.91 $2,427 - $3,690	56 New	56 $2,000

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.07B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.